Kenji Fujita

Company: Atsena Therapeutics

Job title: Chief Medical Officer

Seminars:

Delving Into Emerging Insights for Trial Endpoints Analyzing Correlations Between FST & MLMT 2:30 pm

MLMT is a well-established, clinically meaningful endpoint FST is a reproducible measure of retinal function but has not yet been embraced by the FDA as a clinically meaningful endpoint Correlation between FST and MLMT will be presented, supporting the clinical meaningfulness of changes in FSTRead more

day: Conference Day Two